Summit Therapeutics
SMMT
SMMT
105 hedge funds and large institutions have $205M invested in Summit Therapeutics in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 97 → 105 (+8)
2.35% more ownership
Funds ownership: 4.72% → 7.06% (+2.3%)
Holders
105
Holding in Top 10
–
Calls
$915K
Puts
$211K
Top Buyers
| 1 | +$33M | |
| 2 | +$23.4M | |
| 3 | +$2.69M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.6M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.23M |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$810K | |
| 3 | -$547K | |
| 4 |
SPS
Susquehanna Portfolio Strategies
Bala Cynwyd,
Pennsylvania
|
-$523K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$444K |